VERSANT HCV RNA 3.0 Assay (bDNA)
VERSANT HCV RNA 3.0 Assay (bDNA) accurately quantitates all HCV RNA genotypes.
Equivalent detection of genotypes 1-6
Detection of Genotypes 1-6
Fig 1. Relative recovery of non-1a HCV genotype transcripts compared to that of the genotype 1a transcript.
Transcripts were tested at two concentrations.1
The VERSANT HCV RNA 3.0 Assay (bDNA) helps laboratories reduce their biggest expense: labor.
The VERSANT HCV RNA 3.0 Assay (bDNA) accurately quantitates throughout its broad dynamic range.
- Broad dynamic range (615 to 7,690,000 IU/mL) dramatically reduces repeat testing Saves time, costs, and provides the ability to detect a clinically significant 2-log drop in viral load
Ease of Use
- Familiar ELISA-like format - Easy to learn and train
Low Risk of Sample Contamination
- No viral extraction Eliminates tedious extraction steps (required with PCR assays) that increase risk of cross-contamination
1. Elbeik, T et al. 2004. Multicenter Evaluation of the Performance Characteristics of the Bayer VERSANT HCV RNA 3.0 Assay (bDNA). JCM, 42(2); 563-569.